TEL AVIV, Israel, April 26, 2017 /PRNewswire/ -- 2breathe Technologies Ltd. with its wholly owned U.S. subsidiary Resperate Inc. announced, today, the publication of a new peer reviewed original ...

NEW YORK (Reuters Health) - A device that plays a melody in an attempt to slow people's breathing didn't lower the blood pressure of people with diabetes, according to a new study. "Given the results ...

Could you comment on RESPeRATE, which advertises itself as the “breakthrough medical device clinically proven to lower high BP with no side effects”? —Gerard K. Nash, DO, Amarillo, Tex. The theory ...

RESPeRATE is a noninvasive medical device for the treatment of hypertension (high blood pressure). It works by tracking a person’s breathing and guiding them to breathe more slowly. Original Medicare ...

RESPeRATE is a breathing device approved by the FDA to help lower blood pressure. It’s built on the theory that taking slow and deep breaths can help balance the autonomic functions in the central ...

WASHINGTON (Reuters Health) - A device that helps people bring down their blood pressure by doing breathing exercises has received approval from the US Food and Drug Administration (FDA) for sale over ...